GO:0003723 | RNA binding | 1.54e-04 | 1.00e+00 | 4.568 | 3 | 22 | 247 |
GO:0016149 | translation release factor activity, codon specific | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0030529 | ribonucleoprotein complex | 6.85e-04 | 1.00e+00 | 5.574 | 2 | 5 | 82 |
GO:0034969 | histone arginine methylation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0003747 | translation release factor activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 2 | 2 |
GO:0016274 | protein-arginine N-methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0008469 | histone-arginine N-methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0000398 | mRNA splicing, via spliceosome | 1.66e-03 | 1.00e+00 | 4.931 | 2 | 15 | 128 |
GO:0006449 | regulation of translational termination | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0072341 | modified amino acid binding | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 2 | 4 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0004521 | endoribonuclease activity | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 2 | 5 |
GO:0008380 | RNA splicing | 2.74e-03 | 1.00e+00 | 4.565 | 2 | 21 | 165 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 2 | 6 |
GO:0008409 | 5'-3' exonuclease activity | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 2 | 7 |
GO:0006379 | mRNA cleavage | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 3 | 9 |
GO:0008143 | poly(A) binding | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 10 |
GO:0006479 | protein methylation | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 2 | 11 |
GO:0043022 | ribosome binding | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 2 | 17 |
GO:0006378 | mRNA polyadenylation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 18 |
GO:0031397 | negative regulation of protein ubiquitination | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 18 |
GO:0071346 | cellular response to interferon-gamma | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 21 |
GO:0005057 | receptor signaling protein activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 26 |
GO:0005515 | protein binding | 1.34e-02 | 1.00e+00 | 1.244 | 5 | 198 | 4124 |
GO:0008168 | methyltransferase activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 30 |
GO:0017148 | negative regulation of translation | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 5 | 33 |
GO:0031124 | mRNA 3'-end processing | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 4 | 35 |
GO:0006369 | termination of RNA polymerase II transcription | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 4 | 40 |
GO:0005840 | ribosome | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 40 |
GO:0006406 | mRNA export from nucleus | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 7 | 44 |
GO:0010467 | gene expression | 2.68e-02 | 1.00e+00 | 2.868 | 2 | 49 | 535 |
GO:0071013 | catalytic step 2 spliceosome | 3.09e-02 | 1.00e+00 | 5.001 | 1 | 5 | 61 |
GO:0006415 | translational termination | 3.19e-02 | 1.00e+00 | 4.954 | 1 | 2 | 63 |
GO:0001649 | osteoblast differentiation | 3.73e-02 | 1.00e+00 | 4.722 | 1 | 5 | 74 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 5 | 84 |
GO:0044822 | poly(A) RNA binding | 5.66e-02 | 1.00e+00 | 2.289 | 2 | 45 | 799 |
GO:0005654 | nucleoplasm | 6.69e-02 | 1.00e+00 | 2.157 | 2 | 68 | 876 |
GO:0016874 | ligase activity | 7.26e-02 | 1.00e+00 | 3.742 | 1 | 11 | 146 |
GO:0046872 | metal ion binding | 7.52e-02 | 1.00e+00 | 2.064 | 2 | 24 | 934 |
GO:0016071 | mRNA metabolic process | 8.41e-02 | 1.00e+00 | 3.522 | 1 | 10 | 170 |
GO:0000166 | nucleotide binding | 8.69e-02 | 1.00e+00 | 3.472 | 1 | 13 | 176 |
GO:0006412 | translation | 8.79e-02 | 1.00e+00 | 3.456 | 1 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 8.84e-02 | 1.00e+00 | 3.448 | 1 | 17 | 179 |
GO:0016070 | RNA metabolic process | 9.26e-02 | 1.00e+00 | 3.377 | 1 | 10 | 188 |
GO:0016567 | protein ubiquitination | 9.26e-02 | 1.00e+00 | 3.377 | 1 | 14 | 188 |
GO:0035556 | intracellular signal transduction | 9.78e-02 | 1.00e+00 | 3.295 | 1 | 5 | 199 |
GO:0008283 | cell proliferation | 1.17e-01 | 1.00e+00 | 3.031 | 1 | 8 | 239 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.63e-01 | 1.00e+00 | 2.518 | 1 | 23 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 1.64e-01 | 1.00e+00 | 2.505 | 1 | 11 | 344 |
GO:0044267 | cellular protein metabolic process | 1.68e-01 | 1.00e+00 | 2.472 | 1 | 14 | 352 |
GO:0005783 | endoplasmic reticulum | 1.80e-01 | 1.00e+00 | 2.358 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 1.93e-01 | 1.00e+00 | 2.248 | 1 | 15 | 411 |
GO:0016032 | viral process | 2.01e-01 | 1.00e+00 | 2.190 | 1 | 30 | 428 |
GO:0005829 | cytosol | 2.28e-01 | 1.00e+00 | 1.128 | 2 | 88 | 1787 |
GO:0007165 | signal transduction | 2.79e-01 | 1.00e+00 | 1.660 | 1 | 24 | 618 |
GO:0006355 | regulation of transcription, DNA-templated | 3.16e-01 | 1.00e+00 | 1.450 | 1 | 31 | 715 |
GO:0008270 | zinc ion binding | 3.21e-01 | 1.00e+00 | 1.426 | 1 | 39 | 727 |
GO:0005737 | cytoplasm | 4.09e-01 | 1.00e+00 | 0.569 | 2 | 127 | 2633 |
GO:0016020 | membrane | 4.83e-01 | 1.00e+00 | 0.694 | 1 | 56 | 1207 |
GO:0005730 | nucleolus | 4.86e-01 | 1.00e+00 | 0.682 | 1 | 74 | 1217 |
GO:0005634 | nucleus | 8.67e-01 | 1.00e+00 | -0.733 | 1 | 158 | 3246 |